# Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)

> **NCT02919735** · PHASE2 · COMPLETED · sponsor: **Legacy Healthcare SA** · enrollment: 40 (actual)

## Conditions studied

- Alopecia

## Interventions

- **DRUG:** CG 428 cutaneous solution
- **DRUG:** Placebo cutaneous solution

## Key facts

- **NCT ID:** NCT02919735
- **Lead sponsor:** Legacy Healthcare SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2018-07
- **Final completion:** 2019-03-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02919735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02919735, "Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02919735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*